• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 CONCERTO PGLA HLX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 CONCERTO PGLA HLX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number PV-18-40-HELIX
Medical Device Problem Code Separation Failure (2547)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/15/2021
Type of Reportable Event Malfunction
Event or Problem Description
Medtronic received information that the concerto coil could not be detached with the instant detacher or by manually.The coil was retrieved and another coil was used to continue the procedure.It was noted the device was prepared and inspected per the instructions for use (ifu).There was no harm or injury to the patient.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information received reported that 28 detachment attempts were made with the instant detacher, and 7-8 were made with the manual method.Prior to the non-detachment there were no issues encountered, and no damage was observed to the pushwire after removal.
 
Additional Manufacturer Narrative
Product analysis: as found condition- two coils were returned for analysis within in a shipping box, within a sealed plastic biohazard pouch; within an opened concerto outer carton; within an opened concerto inner pouch and within a plastic pouch.Visual inspection/damage location details: the pusher was found broken at the break indicator, indicative of a manual detachment attempt at this location.The proximal segment (actuator interface, positive load indicator, and portion of the break indicator and coupler tube) was not returned for analysis.Therefore, evidence of detachment attempts using an instant detacher could not be assessed.The release wire was found extending out of the distal segment.The coin was found still against the lumen stop.The shield coil was found intact and unstretched.The implant coil was found still attached to the pusher.The implant coil was found to be undamaged.It is likely the implant coil was still attached to the pusher.Testing/analysis ¿ the exposed release wire was retracted, and the coin retracted out of the lumen stop with no issues and no resistance encountered.The implant coil became detached with no other issues found.Conclusion - based on the customer report and device analysis, the customer report of "non-detachment" was confirmed for the first coil.It is likely the cause of the non-detachment is the release wire became separated from the actuator interface causing the release wire to not retract during the detachment attempts.When the release wire was retracted during in-house analysis, the coin exited the lumen stop and the implant coil detached as expected by the detachment elements.The cause of the detachment from the actuator interface could not be determined.As the proximal segment of the pusher was not returned, the crimps could not be confirmed.The instant detacher used in the event was not returned.Therefore, any contribution of the instant detacher towards the non-detachment could not be determined.It is possible the issue could be related to a manufacturing issue, therefore, a device history review will be conducted.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONCERTO PGLA HLX
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key12493070
Report Number2029214-2021-01175
Device Sequence Number3349955
Product Code KRD
UDI-Device Identifier00847536033672
UDI-Public00847536033672
Combination Product (Y/N)N
Initial Reporter CountryHK
PMA/510(K) Number
K090046
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 12/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/12/2024
Device Model NumberPV-18-40-HELIX
Device Catalogue NumberPV-18-40-HELIX
Device Lot NumberB205285
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/23/2021
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/15/2021
Supplement Date Received by Manufacturer09/20/2021
12/08/2021
Initial Report FDA Received Date09/17/2021
Supplement Report FDA Received Date10/14/2021
12/14/2021
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/13/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age64 YR
Patient SexFemale
-
-